**Core Concept**
Pulmonary hypertension is a complex condition characterized by elevated blood pressure in the pulmonary arteries, leading to right ventricular failure and potentially life-threatening complications. The pathophysiology involves vascular remodeling, endothelial dysfunction, and altered vasoreactivity, which can be triggered by various underlying causes.

**Why the Correct Answer is Right**
The correct answer is related to the concept of endothelin-1 (ET-1), a potent vasoconstrictor peptide that plays a crucial role in the pathogenesis of pulmonary hypertension. ET-1 levels are elevated in patients with pulmonary hypertension, and its blockade has been shown to improve hemodynamics and symptoms. ET-1 exerts its effects by binding to endothelin receptors, specifically ETA and ETB receptors, which are expressed on pulmonary vascular smooth muscle cells and endothelial cells.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while chronic thromboembolic pulmonary hypertension (CTEPH) is a cause of pulmonary hypertension, it is not the most common underlying mechanism.
**Option B:** This option is incorrect because while left heart disease can lead to pulmonary hypertension, it is not the primary cause of the condition.
**Option C:** This option is incorrect because while hypoxia can lead to pulmonary hypertension, it is not the most direct cause of the condition.

**Clinical Pearl / High-Yield Fact**
The "5 M's" of pulmonary hypertension are a useful mnemonic to remember the common causes of the condition: Mitral valve disease, Microvascular disease, Mixed connective tissue disease, Monocrotaline toxicity, and Methamphetamine abuse.

**Correct Answer: D. Endothelin-1.**